Page 3 - Synchron Switch News Today

Synchron is part of an emerging crop of companies testing technology in the brain-computer interface industry, reports CNBC.The

Brain implant startup backed by Bezos and Gates is testing mind-controlled computing on humans

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Synchron, the endovascular brain-computer interface company, announced today an oversubscribed $75 million Series C financing round.

Billionaires Bill Gates and Jeff Bezos are betting on the New York-based Synchron as the answer to Elon ...

The funding will accelerate development of Synchron’s first platform product (Synchron SwitchTM BCI), and launch a pivotal clinical trial.

Synchron announced today that it raised an oversubscribed $75 million Series C financing round for its brain-computer interface (BCI).

Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.

Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!